Compositions for treatment of ocular diseases | Patent Number 11873279

US 11873279 B2
Application Number17879627
Publication NumberUS 20230120974 A1
Pendency1 year, 5 months, 17 days
Filled DateAug 2, 2022
Priority DateFeb 6, 2020
Publication DateApr 20, 2023
Expiration DateFeb 5, 2040
Inventor/ApplicantsDavid Floyd
Zhongli Ding
Sevgi Gurkan
ExaminesRAO, PADMAJA S
Art Unit1627
Technology Center1600
Assignments
Applaud Medical Inc.
Current
Perfuse Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.